Q4 Earnings Forecast for ALHC Issued By Leerink Partnrs

Alignment Healthcare, Inc. (NASDAQ:ALHC) – Analysts at Leerink Partnrs issued their Q4 2026 EPS estimates for shares of Alignment Healthcare in a research note issued to investors on Thursday, February 27th. Leerink Partnrs analyst W. Mayo anticipates that the company will post earnings per share of ($0.11) for the quarter. The consensus estimate for Alignment Healthcare’s current full-year earnings is ($0.69) per share. Leerink Partnrs also issued estimates for Alignment Healthcare’s FY2029 earnings at $0.93 EPS.

A number of other analysts have also recently commented on ALHC. Stephens reissued an “overweight” rating and issued a $17.00 price target on shares of Alignment Healthcare in a research report on Monday, February 24th. Barclays boosted their target price on Alignment Healthcare from $8.00 to $9.00 and gave the stock an “underweight” rating in a report on Friday. William Blair restated an “outperform” rating on shares of Alignment Healthcare in a report on Friday. Finally, Stifel Nicolaus lifted their price target on Alignment Healthcare from $16.00 to $18.00 and gave the stock a “buy” rating in a research report on Friday. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Alignment Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $12.25.

Alignment Healthcare Price Performance

Shares of ALHC opened at $15.52 on Monday. Alignment Healthcare has a fifty-two week low of $4.46 and a fifty-two week high of $16.25. The firm’s 50-day simple moving average is $13.60 and its two-hundred day simple moving average is $12.04. The stock has a market cap of $2.98 billion, a PE ratio of -20.16 and a beta of 1.50. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60.

Institutional Trading of Alignment Healthcare

Several large investors have recently modified their holdings of ALHC. Creative Planning lifted its holdings in Alignment Healthcare by 20.0% in the third quarter. Creative Planning now owns 12,442 shares of the company’s stock valued at $147,000 after acquiring an additional 2,072 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Alignment Healthcare by 3.9% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 56,963 shares of the company’s stock valued at $641,000 after purchasing an additional 2,154 shares during the last quarter. Rhumbline Advisers lifted its stake in shares of Alignment Healthcare by 2.2% in the 4th quarter. Rhumbline Advisers now owns 135,704 shares of the company’s stock worth $1,527,000 after purchasing an additional 2,937 shares during the period. MetLife Investment Management LLC boosted its holdings in shares of Alignment Healthcare by 5.6% in the fourth quarter. MetLife Investment Management LLC now owns 61,344 shares of the company’s stock worth $690,000 after buying an additional 3,256 shares during the last quarter. Finally, Alliancebernstein L.P. boosted its holdings in shares of Alignment Healthcare by 2.8% in the fourth quarter. Alliancebernstein L.P. now owns 119,440 shares of the company’s stock worth $1,344,000 after buying an additional 3,300 shares during the last quarter. Institutional investors own 86.19% of the company’s stock.

Insider Activity at Alignment Healthcare

In other Alignment Healthcare news, insider Hyong Kim sold 62,574 shares of Alignment Healthcare stock in a transaction that occurred on Thursday, December 5th. The shares were sold at an average price of $12.20, for a total value of $763,402.80. Following the completion of the sale, the insider now owns 470,496 shares of the company’s stock, valued at approximately $5,740,051.20. The trade was a 11.74 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO John E. Kao sold 90,000 shares of the business’s stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $11.65, for a total transaction of $1,048,500.00. Following the sale, the chief executive officer now owns 2,363,100 shares of the company’s stock, valued at approximately $27,530,115. This represents a 3.67 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 441,002 shares of company stock valued at $5,772,726 over the last ninety days. Insiders own 6.60% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.